Trevi Therapeutics, Inc.·5

Feb 13, 4:30 PM ET

BASKETT FOREST 5

5 · Trevi Therapeutics, Inc. · Filed Feb 13, 2026

Insider Transaction Report

Form 5
Period: 2025-12-31
Transactions
  • Exercise of In-Money

    Common Stock

    [F1]
    2025-04-17$1.37/sh+1,851,852$2,537,03712,273,280 total(indirect: See Note 1)
  • Exercise of In-Money

    3.5-Year Common Stock Warrant

    [F1]
    2025-04-171,851,8520 total(indirect: See Note 1)
    Exercise: $1.37From: 2021-10-18Exp: 2025-04-18Common Stock (1,851,852 underlying)
Footnotes (1)
  • [F1]The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 16 securities in which the Reporting Person has no pecuniary interest.
Signature
/s/ Zachary Bambach, attorney-in-fact|2026-02-13

Documents

1 file
  • 5
    ownership.xmlPrimary

    5